W. S. Clemente

DFT analysis of gamma-secretase interactions with potential inhibitors: therapeutic for Alzheimer's disease.

In this study, molecular-level insights are provided into the interaction mechanisms of γ-secretase inhibitors, contributing to a better understanding of structure-energy relationships that are essential for the rational design of more selective and effective therapeutic agents for Alzheimers disease.